WORX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
WORX is not a good buy right now for an impatient investor. There are no Intellectia buy signals, price action is weak below key pivot resistance, and fundamentals show shrinking revenue and worsening EPS despite a gross margin rebound. With no news catalysts and no notable smart-money or political activity, the risk/reward is unattractive for an immediate entry.
Price closed at 0.1934 (-1.88%) and is trading below the key pivot level (0.231), which keeps the near-term bias cautious-to-bearish. RSI(6) at ~49 is neutral (no momentum edge). MACD histogram is slightly positive (0.00294) but contracting, implying bullish momentum is fading rather than strengthening. Moving averages are converging, consistent with consolidation rather than a clear uptrend. Key levels: support S1=0.178 then S2=0.145; resistance R1=0.284 then R2=0.317. With price below pivot, the setup favors a drift/whipsaw unless it reclaims 0.231 decisively. Pattern-based projection indicates a 70% chance of -1.13% next day, +3.26% next week, and -1.38% next month—mixed, but not compelling for an immediate buy.
Gross margin improved to 35.69% (up sharply YoY), which can support a short-term bounce if revenue stabilizes. Price is relatively close to support (0.178), so a technical oversold-to-bounce move is possible if buyers defend that level.
No news in the past week (no event-driven upside catalyst). Revenue declined -7.10% YoY (2025/Q3). EPS worsened to -0.15 YoY. Net income is still negative (-1.31M), indicating ongoing losses. Intellectia signals show no AI Stock Picker or SwingMax buy trigger, removing a key tactical reason to enter now. Trading trends show hedge funds and insiders are neutral (no strong conviction flows). No recent Congress trading data (no political/influential accumulation signal).
Latest quarter: 2025/Q3. Revenue fell to 705,799 (-7.10% YoY), indicating top-line contraction. Net income improved YoY to -1,312,539 (still a loss), suggesting costs/one-offs may have helped but profitability remains negative. EPS declined to -0.15 (down -44.44% YoY), reinforcing that shareholder-level earnings deteriorated. Gross margin rose to 35.69% (up materially YoY), a bright spot, but it has not translated into positive earnings yet.
No analyst rating/price target change data provided, so a Wall Street pros/cons consensus cannot be confirmed from the dataset. Based on provided fundamentals alone: Pros—gross margin improvement. Cons—revenue decline, ongoing losses, and lack of near-term catalysts/signals.
